# The Effect of Simvastatin on Breast Cancer Cell Growth in Women With Stage I-II Breast Cancer

> **NCT03454529** · PHASE2 · COMPLETED · sponsor: **Michael Simon** · enrollment: 24 (actual)

## Conditions studied

- Invasive Breast Carcinoma
- Stage I Breast Cancer AJCC v7
- Stage IA Breast Cancer AJCC v7
- Stage IB Breast Cancer AJCC v7
- Stage II Breast Cancer AJCC v6 and v7
- Stage IIA Breast Cancer AJCC v6 and v7
- Stage IIB Breast Cancer AJCC v6 and v7

## Interventions

- **OTHER:** Laboratory Biomarker Analysis
- **DRUG:** Simvastatin

## Key facts

- **NCT ID:** NCT03454529
- **Lead sponsor:** Michael Simon
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-09
- **Primary completion:** 2021-10-06
- **Final completion:** 2021-10-06
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2023-08-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03454529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03454529, "The Effect of Simvastatin on Breast Cancer Cell Growth in Women With Stage I-II Breast Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03454529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*